Platelet-derived growth factor (PDGF)-BB can induce abnormal proliferation and migration of vascular smooth muscle cells (VSMC) that are involved in the development of CVD. In our preliminary study, phytoalexin glyceollins (glyceollins I, II and III) isolated from soyabean seeds cultured with Aspergillus sojae showed strong antioxidant and anti-inflammatory activity. Since antioxidants showed beneficial effects on chronic inflammatory diseases, the purpose of the present study was to examine the effects of glyceollins on PDGF-induced proliferation and migration in human aortic smooth muscle cells (HASMC). Incubation of resting HASMC with glyceollins for 24 h significantly diminished PDGF-increased cell number and DNA synthesis in a dose-dependent manner without any cytotoxicity. In addition to blocking of the PDGF-inducible progression through the G 0 /G 1 to the S phase of the cell cycle, glyceollins down-regulated the expression of cyclindependent kinase (CDK)2 and cyclin D1, and up-regulated the expression of CDK inhibitors such as p27 kip1 and p53.Glyceollins also effectively inhibited reactive oxygen species generation and phosphorylation of PDGF receptor-b, phospholipase Cg1, Akt and extracellular signal-regulated kinase 1/2 by PDGF stimulation. Furthermore, glyceollins were found to inhibit PDGF-induced dissociation of actin filaments and cell migration. Thus, the results suggest that glyceollins could become a potent therapeutic agent for regulating VSMC-associated vascular disease such as atherosclerosis and restenosis after angioplasty.
Accumulation of vascular smooth muscle cells (VSMC) is a key event in the formation and development of lesions of atherosclerosis. The excessive accumulation of VSMC is due to a combination of directed migration from the media into the intima of the artery accompanied by proliferation and possibly decreased apoptosis. The proliferation and migration of VSMC are involved in vascular remodelling and intimal lesion formation, and these can be induced by various growth factors, such as platelet-derived growth factor (PDGF) or basic fibroblast growth factor (1 -4) . PDGF is expressed by platelets, smooth muscle cells, endothelial cells and macrophages, and PDGF-BB among the PDGF isomers is a potent inducer of VSMC proliferation and migration compared with PDGF-AA and PDGF-AB (2 -4) .
Although the role of PDGF on vascular biology is important, the mechanisms related to PDGF-stimulated smooth muscle cell proliferation and migration have not been fully elucidated. Several studies have reported that PDGF interferes with actin filament assembly and causes marked up-regulation of PDGF receptor (PDGFR) expression after injury to the vessel wall (5) . In an animal model, infusion of PDGF-BB promoted intimal thickening and promoted VSMC migration from the media to intima (6) , and the blocking of PDGFR decreased in smooth muscle cell growth and neointimal formation in response to injury (7) . Some studies also showed that activation of mitogen-activated protein kinase (MAPK) (extracellular signal-regulated kinases; ERK1/2) is implicated in the PDGFmediated DNA synthesis and proliferation process (8) , and the ability of the PDGF to activate phospholipase C (PLC)g1 and phosphoinositide 3-kinase (PI3K)/Akt correlated with its ability to induce migration of smooth muscle cells rather than DNA synthesis and proliferation (9) . Furthermore, PDGFR transports its signal into the intracellular space by the generation of reactive oxygen species (ROS). For instance, H 2 O 2 was related to stimulation of the phosphorylation of ERK1/2 in PDGF-stimulated VSMC proliferation (10) . Isoflavone-rich soya foods, soya protein isolate and isoflavone extracts have been reported to improve cognitive performance (11, 12) , menopausal symptoms (13, 14) , bone health (15) , hypertension (16) as well as prevent lipid peroxidation (17, 18) , and breast (19) and prostate cancers (20, 21) . In addition, several studies demonstrated that soya protein with isoflavones exhibited atheroprotective effects by increasing HDL-cholesterol, reducing vascular inflammation and platelet aggregation, and inhibiting human aortic smooth muscle cell (HASMC) proliferation (22) . Isoflavones scavenge free radicals that are involved in platelet stimulation, suggesting novel anti-aggregatory mechanism of isoflavones (23) . Furthermore, soya-isoflavone supplementation reduced NF-kB activation induced by TNF-a in human lymphocytes (24) . Genistein, in particular, activates endothelial NO synthase (eNOS) by stimulation of cAMP production, leading to the phosphorylation of eNOS. These results indicate that isoflavones have specific pathways by which these oestrogen-like components induce vasodilatory effects (25) . Treatment of human umbilical vein endothelial cells (HUVEC) with genistein resulted in a dose-dependent inhibition of TNF-a-induced expression of adhesion molecules such as E-selectin, vascular cell adhesion molecule-1 and inter-cellular adhesion molecule-1 (26) . Genistein and daidzein not only inhibited NO production via suppression of inducible NO synthase in activated macrophages but also reduced monocyte chemotactic protein (MCP)-1 secretion (27) . Glyceollins, which are synthesised from daidzein in soyabeans cultured with Aspergillus sojae, have been shown to have cancer-preventive properties (28, 29) and represent another group of phytoalexins whose biosynthesis is increased in soyabean in response to various stress signals such as fungal infection (30, 31) . Flavonoids are a group of widely distributed plant polyphenols having antioxidant activity. As glyceollins have similar structure to other soyabean isoflavonoids ( Fig. 1) , it is presumed that they share common physiological properties. Research in our laboratory showed a marked oestrogenic activity of glyceollins in vitro on oestrogen receptor signalling (32) . Moreover, our recent preliminary studies show that glyceollins have anti-inflammatory and antioxidant activity.
In the present study, the anti-atherosclerotic effects of glyceollins derived from soyabean elicited with fungi were evaluated and found that these compounds can inhibit the PDGF-stimulated proliferation and migration of HASMC.
Experimental methods

Preparation of glyceollins
A mixture of glyceollins I, II and III was isolated according to the method described previously (32) . Briefly, glyceollin-rich extract was prepared by inoculation of soyabean seed with A. sojae in a dark chamber at 268C for 3 d. After homogenisation in 80 % aqueous ethanol and incubation, the filtered extract was freeze-dried. The ethyl acetate soluble fraction of the crude extract was subjected to silica gel column chromatography. One fraction was subjected to TLC and HPLC to confirm existence of glyceollins, and then the fraction was evaporated under reduced pressure.
Cell culture
HASMC were obtained from Cascade Biologics, Inc. (Portland, OR, USA). For routine maintenance, cells were grown in Dulbecco's modified Eagle's medium (DMEM; Gibco, Grand Island, NY, USA) supplemented with 10 % heat-inactivated fetal bovine serum at 378C in an atmosphere of 5 % CO 2 -95 % air under saturating humidity and passaged every week (1:4 split ratio) by trypsinisation with 0·25 % trypsin -0·02 % EDTA sodium salt solution (Thermo Fisher Scientific Inc., Waltham, MA, USA).
Cell proliferation assay
The experimental procedures were performed according to previously described methods with some modifications. Briefly, HASMC were trypsinised and plated into ninety-sixwell plates with the DMEM at an initial concentration of 1 £ 10 4 cells per well and incubated in an atmosphere consisting of 5 % CO 2 in air at 378C for 24 h. Then the medium was removed and replaced by the medium containing a range of concentrations of test compounds in serum-free DMEM. The bioassay was terminated on day 1 by removing the medium from the wells, and adding 3-[4,5-dimethyl-thiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) solution (0·5 mg/ml in phenol red-free culture medium). After 2 h, the solution was removed and 200 ml dimethylsulfoxide (DMSO) were added. After 10 min, the absorbance was determined at 540 nm by a 
Synthesis assay
Thymidine incorporation experiments were carried out according to a previously described method (33) . The HASMC were cultured until they reached about 40 % confluence. The culture medium was changed with serum-free medium and incubated for 24 h. The serum-deprived cells were then pre-incubated with glyceollins for 24 h and stimulated with/ without PDGF or with/without glyceollins for 20 h. After the incubation, 1 mCi/ml (37 000 Bq) of [ 3 H]thymidine was added to the cultures and incubated for 4 h at 378C. The cells were harvested using a Universal Harvester (Perkin Elmer, Waltham, MA, USA), and transferred to a GF/C filter (Perkin Elmer). The filter was dried and the level of radioactivity was determined using a Microplated Scintillation and Luminescence Counter-Topcount NXT (Perkin Elmer). The values were calculated from absolute counts to a percentage of the control to allow comparison between the experimental groups.
Cell cycle analysis
Cell cycle progression analysis was measured as described previously (34) . HASMC were seeded in six-well plates at 2 £ 10 5 cells/well and incubated until the cell density reached 80 %. Then the medium was replaced with serum-free medium and incubated for 24 h. The cells were then pre-incubated with glyceollins for 24 h and stimulated with/without PDGF or with/without glyceollins for 24 h. The HASMC were harvested, re-suspended in 70 % ethanol, and incubated at 2 208C for 4 h. The fixed cells were washed twice with PBS, and incubated at 378C for 60 min using a solution containing DNAse-free RNAse (200 mg/ml). After incubation, the cells were stained with propidium iodide (50 mg/ml) at 48C for 30 min and subjected to a flow cytometric analysis (Becton Dickinson, Franklin Lakes, NJ, USA).
Migration assay
Cell migration was measured using a modified Boyden transwell chamber (twenty-four-well plate) assay as described in our previous study (33) . Starved cells were trypsinised and cell suspension in basal medium (500 ml, 5 £ 10 4 cells/well) seeded in the upper chamber. Then, 760 ml of serum free medium with or without experimental compounds were added to the lower chamber. After incubation for 24 h, the cells were labelled by fluorescence dye calcein-acetoxymethyl ester (AM) (4 mg/ml). The cells migrated to the lower chamber were measured using a fluorescence microplate reader at 485 nm excitation and 530 nm emission wavelengths. Each treatment was repeated in three independent transwells.
Wound healing assay
When the HASMC had grown to 80 % confluence in the eightwell plate, a scratch was made with a sterile cell scraper as described in a previous study (35) . Cells were washed with PBS twice, were incubated for 18 h with or without glyceollins (3 mg/ml) in the presence or absence of PDGF (20 ng/ml) in serum-free medium, stained with haematoxylin and eosin. The plates were photographed and the wound width was calculated by a microruler.
Dichlorofluorescein assay
Oxidative stress was quantified in cells by the dichlorofluorescein (DCF) assay according to the method described by Wang & Joseph (36) , with slight modifications. Briefly, HASMC were seeded into black-bottom ninety-six-well plates, and cultured for 24 h. After attachment, plates were washed with PBS and the cells were incubated with H 2 O 2 (1000 mM) for 2 h before treatment with increasing concentrations of each generation of experimental compounds prepared in serum-free media for 24 h. The stimulated cells were washed with PBS and incubated for 30 min with dichlorofluoresceindiacetate, dissolved in DMSO (final concentration 50 mM). Fluorescence was measured at 0 and 40 min using excitation and emission wavelengths of 485 and 535 nm, in a Tecan microplate reader (Tecan). All dye and oxidant incubations, washing steps and fluorimetric determination were performed in a dark room. The intensity of fluorescence was calculated as ((F 40 min 2 F 0 min )/F 0 min ) £ 100 as described. Results are expressed as relative intensity of fluorescence (as % of H 2 O 2 control).
Dihydroethidium assay
The production of superoxide anion in HASMC was measured using the oxidation-sensitive dye dihydriethidium (37) . HASMC were stained by incubation for 30 min at 378C with 10 mM-dihydriethidium (Sigma). The cells were washed with PBS twice, and photographed using a Nikon Eclipse 80i fluorescence microscope and a Nikon Digital Sight DS-Fi1c camera (Nikon, Tokyo, Japan).
Western blotting
HASMC were homogenised in pre-cooled radio-immunoprecipitation assay (RIPA) buffer (pH 7·4) containing 2-amino-2-hydroxymethyl-propane-1,3-diol (Tris)-HCl (50 mM), NaCl (150 mM), EDTA (1 mM), Triton-X (1 %), sodium deoxycholate (0·5 %) and SDS (0·1 %). The homogenates were cleared by centrifugation at 9000 rpm for 5 min at 48C, and the supernatant fractions were denatured in sample buffer for 5 min at 958C. Proteins were separated by electrophoresis on a 10 % SDS-polyacrylamide gel for 1·5 h at 70 -150 V and transferred onto nitrocellulose membranes (Amersham Biosciences, Freiburg, Germany) for 2 h at 250 mA. Membranes were incubated with antibodies to phosphorylated PDGFR-b, PDGFR-b, phosphorylated Akt, Akt, phosphorylated PLCg, PLCg, phosphorylated MAPKinases, MAPKinases, cyclin-dependent kinase (CDK)1, CDK4, cyclin D1, cyclin E, p27 kip1 , p21 cip1 , p53 and b-actin at dilutions of 1:1000 overnight at 48C. The bands were detected using a chemiluminescence kit (Pierce, Chester, Cheshire, UK). Densitometry analysis was performed with Lab Image software (Scion Corp., Walkerville, MD, USA).
Statistical analysis
All values are expressed as mean values and standard deviations. For statistical significance, unpaired Student's t tests were used. A significant difference was indicated at P,0·05.
Results
Effects of glyceollins on human aortic smooth muscle cell proliferation and platelet-derived growth factorstimulated cycle progression When HASMC were stimulated by PDGF-BB (20 ng/ml), the number of cells increased by approximately 34·5 % compared with the non-stimulated group. Treatment with glyceollins (0·3-3 mg/ml) for 24 h in PDGF-stimulated HASMC resulted in a significant decrease in cell number without any cytotoxicity. The ratio of inhibition was 13·6 (SD 2·3), 16·7 (SD 4·1) and 30·7 (SD 4·6) % at 0·3, 1·5 and 3 mg/ml, respectively ( Fig. 2(a) ). There was no significant change in cell morphology in cultures treated with PDGF plus glyceollins ( Fig. 2(c) ). The effect of glyceollins on DNA synthesis was assayed by The DNA content was analysed by propidium iodide staining to investigate the effect of glyceollins on cell cycle progression in HASMC. PDGF-BB (20 ng/ml) induced an increase in the S phase from 2·3 % to 18·1 % compared with the control. Glyceollins dose-dependently decreased accumulation at the S phase to 11·3 % at 0·3 mg/ml, 8·2 % at 1·5 mg/ml and 5·6 % at 3 mg/ml in PDGF-treated cells in a dose-dependent fashion. These results indicate that glyceollins were effective in arresting PDGF-stimulated cell cycle progression in HASMC.
Effects of glyceollins on the expression of cell cycle-related proteins
Cell cycle progression is tightly regulated through a complex network of positive and negative cell cycle-regulatory molecules such as CDK and cyclins. To investigate whether inhibition of proliferation by glyceollins involves the regulation of cell cycle-related proteins, we assessed the expression of G 1 -checkpoint proteins in glyceollin-treated cell cycle arrest. As shown in Fig. 3(c) , glyceollins significantly decreased the level of CDK2 and cyclin E, but did not change the levels of CDK4 and cyclin D. Therefore, these findings suggest that glyceollins affect the transition of HASMC from the G 1 to the S phase, together with its inhibitory effects on HASMC proliferation. The effect of glyceollins on the expression level of CDK inhibitor p27 kip1 and p53 was further clarified. The protein levels of p27 kip1 and p53 were reduced at 24 h after stimulation by PDGF, while they were significantly enhanced in HASMC treated with glyceollins in a dose-dependent manner. The expression of p21 cip1 protein was not influenced by PDGF or glyceollins.
Effects of glyceollins on signalling pathway related to platelet-derived growth factor PDGF-induced expression of proteins such as PDGFR-b, PLCg1 and Akt was detected to investigate the inhibitory mechanism of glyceollins on the signal transduction pathway of PDGF for HASMC proliferation and migration. HASMC were stimulated with PDGF-BB (20 ng/ml) for 15 min, which caused obvious phosphorylation of PDGFR-b, PLCg1, Akt and ERK1/2, and the increased phosphorylation was suppressed by glyceollins of various concentrations, suggesting that the anti-proliferative effect of glyceollins was implicated in early signal transduction by PDGF (Fig. 4(a) ). Since PDGF is capable of inducing the activation of MAPK for VSMC proliferation (9) , we investigated the effects of glyceollins on the PDGF signalling pathway by measuring the phosphorylation levels of MAPK including p38, c-Jun N-terminal protein kinase (JNK) and ERK1/2 with Western blotting (Fig. 4(b) ) in HASMC. As shown in Fig. 4(b) , PDGF substantially increased ERK1/2 phosphorylation, but not p38 and JNK phosphorylation, at 15 min after stimulation, whereas cells incubated with glyceollins at various concentrations (0·3, 1·5 and 3 mg/ml) diminished the ERK1/2 phosphorylation. Unlike ERK1/2, JNK and p38 phosphorylation were not affected by glyceollins, indicating that Role of reactive oxygen species on glyceollin-mediated inhibition of intracellular signalling transduction by platelet-derived growth factor
Various ROS are associated with PDGFR-mediated signalling events (10, 38) and can affect the activation of MAPK (39) . To confirm the role of ROS in glyceollin-mediated inhibition of the PDGF signalling pathway, dichlorofluorescein and dihydroethidium (DHE) assays were carried out. The results revealed that PDGF-BB (20 ng/ml) induced ROS formation up to 2·1-fold compared with DMSO-treated cells as control, whereas treatment with glyceollins (0·3, 1·5 and 3 mg/ml) markedly inhibited the reaction to 10·5 (SD 1·2), 12·3 (SD 1·2) and 25·1 (SD 1·3) %, respectively (Fig. 5(a) ). Furthermore, the dihydriethidium assay ( Fig. 5(b) ) showed that glyceollins also remarkably inhibited superoxide anion production stimulated by PDGF. These results indicate that glyceollins negatively regulate PDGF-increased ROS generation in VSMC.
Effects of glyceollins on platelet-derived growth factorstimulated human aortic smooth muscle cell migration
In order to investigate the effect of glyceollins on HASMC migration, the cells were treated for 24 h with different concentrations of glyceollins in the presence or absence of PDGF in a Boyden chamber. The cells that migrated to the lower chamber were stained with calcein-AM, and were photographed with a fluorescence microscope. As shown in Fig. 6 , treatment with glyceollins alone had no significant effect on HASMC migration compared with the DMSO-treated cells. However, PDGF significantly increased migration up to about 291·7 (SD 8) %, while glyceollins effectively inhibited the PDGF-stimulated cell migration at 3 mg/ml.
To confirm the effect of glyceollins on the cell migration assay, we carried out a wound healing assay, and observed the cellular morphology and migration behaviour after treatment with glyceollins. As shown in Fig. 7 , glyceollins alone did not induce any change in the migration compared with control, whereas treatment with PDGF substantially promoted cell migration and cellular morphological change during the wound-healing process at the same time. However, glyceollins significantly reduced the PDGF-induced cell migration up to same level as the non-treated group.
Effect of glyceollins on rearrangement of actin filaments by platelet-derived growth factor
Since it is known that the active rearrangement of actin filaments is related to VSMC migration, we attempted to determine the effects of glyceollins in cells stimulated by PDGF-BB (Fig. 8) . Treatment with glyceollins alone did not result in any change in actin microfilaments of HASMC. On the contrary, incubation with glyceollins (3 mg/ml) prevented the PDGF-induced loss of microfilaments, and the appearance of actin filaments looked similar in cells treated with either DMSO or glyceollins only.
Discussion
Many studies have shown anti-atherosclerotic effects by the components of various natural products such as polyphenols (40 -42) and flavonoids with antioxidant activity (43 -45) . Oestrogen has been demonstrated to have anti-atherosclerotic effects (46) . The beneficial effects of soya isoflavones, a group of natural phyto-oestrogens, on atherosclerosis have been known to be associated with oestrogenic properties. Several studies on the oestrogenic soya isoflavone genistein showed its inhibitory effects on not only the immune reaction (47) , but also the proliferation and migration of VSMC (48) . As the signalling pathway associated with VSMC, genistein inhibited smooth muscle cell proliferation through the increase in p27 kip1 in vivo (49) . Glyceollins have been known to be de novo synthesised in raw soyabean exposed to some biotic elicitors such as fungi 
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and have also been reported to have oestrogenic activity (32) . Our preliminary studies showed that glyceollins have antiinflammatory effects on the lipopolysaccharide-induced immune response of RAW264·7 cells. Furthermore, our previous study demonstrated that the glyceollins have strong antioxidant potential in radical-scavenging activity, and inhibitory activity against singlet oxygen and lipid peroxidation. The radical-scavenging activity of glyceollins as assessed by the 2,2 0 -azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) assay has been shown to be higher than daidzein but similar to genistein (50) . Considering that 84 % of the mixture is glyceollin I, it is possible to speculate that glyceollin I could be the major compound for the antioxidant activity of the glyceollin mixture. Several studies also supported our presumption that glyceollin isomer I had stronger physiological activity than isomers II and III (51, 52) . In the present study, we investigated the effects of glyceollins on PDGF-induced proliferation and migration of HASMC, and evaluated the mechanism of action of glyceollins. The present results demonstrated that glyceollins potently inhibited the PDGF-stimulated proliferation and DNA synthesis without cytotoxicity. The cell cycle is controlled by changes in the expression of cell cycle-regulatory proteins such as phosphorylated retinoblastoma protein (pRB), CDK, cyclins, CDK inhibitor proteins p21 cip1 and p27 kip1 , and tumour suppressors including p53 (53 -55) . CDK2 and CDK4 are key mediators during the G 0 /G 1 to S phase progression of the cell cycle and form complexes with cyclin E and cyclin D1, respectively. These complexes phosphorylate pRB and then release transcription factors that promote DNA synthesis (54 -57) .
The inhibitory effects of glyceollins on PDGF-induced proliferation might be due to the G 0 /G 1 -S phase arrest, which was, in turn, mediated by reduced expression of cyclin E and CDK2, and increased p27 kip1 and p53 expressions. On the other hand, glyceollins did not have any effect on the expression of cyclin D1, CDK4 and p21 cip1 in PDGF-stimulated HASMC. Although numerous CDK are involved in the activation of pRB, the suppression of CDK2 might be enough to inhibit the phosphorylation of pRB (58, 59) . In fact, the previous study suggested that inhibition of CDK4 might not be necessary for cell cycle progression arrest (60, 61) . Therefore, inhibition of CDK2/cyclin E expression may be sufficient for cell cycle arrest. This result indicates that glyceollins have influence on signal transduction events in the G 0 /G 1 -S interphase rather than those involved in the S-G 2 /M phase. Proliferation of VSMC plays an important role in the progression of atherosclerosis and restenosis after vascular injury and PDGF, a peptide growth factor, triggers signals for the proliferation of VSMC through the autophosphorylation of PDGFR and the interaction with cytoplasmic proteins including PLCg, PI3K/Akt, the signal transducers and activators of transcription (STAT) family, and ROS production (62 -64) .
In agreement with previous studies on inhibitory effects of an antioxidant derivative, a PDGF-Rb antagonist or protein kinase inhibitor through inactivation of proteins mentioned above (62 -65) , the present study demonstrated that glyceollins reduced the activation of PDGFR-b, ERK1/2, Akt and PLCg1 in PDGF-stimulated HASMC. In addition, PDGF increases the intracellular concentration of ROS in VSMC. These effects were abolished by a ROS scavenger, resulting in a decrease in VSMC proliferation (38, 64) . H 2 O 2 derived from superoxide anions can form hydroxyl radicals, and which, in turn, leads to phosphorylation of ERK1/2 and PLCg1 in VSMC (63 -65) . It was shown that an antioxidant derivative abolished this reaction of H 2 O 2 ( 66) . The present results show that glyceollins obviously inhibit the PDGF-induced production of superoxide anions as well as other ROS in HASMC, and diminish the PDGF phosphorylation of PDGFR-b, PLCg1, Akt and ERK. Particularly, unlike the activation of Akt by PDGF, the total Akt protein was decreased. According to a previous study, PDGF gave rise to regulated proteolytic down-regulation of Akt by PI3K and proteasome activities, resulting in controlling the activity and function of Akt in VSMC (67) . In agreement with the results from proliferation, cell cycle progression and PDGF-signal transduction mechanisms, glyceollins also blocked the PDGF-treated HASMC migration.
The purity of glyceollins isolated from a methanolic extract of A. sojae-inoculated sprouting soyabeans was determined to be over 95 % by HPLC-mass analysis and the relative ratio of glyceollin isomers I, II and III was 12:1·3:1, respectively. Therefore, the biological activity observed with crude glyceollins in the study is most likely to be attributable to the glyceollins themselves.
The concentrations of glyceollin mixture used in the present study were 0·3, 1·5 and 3 mg/ml which are equivalent to 1, 5 and 10 mM (glyceollin I), unless specially indicated. The concentration of isoflavones used in most studies ranged from 16 to 500 mM, although some studies reported physiological activity of genistein or daidzein at doses as low as 0·1 -20 mM (68, 69) . The concentration of glyceollins used in the study is physiologically relevant because it could be readily achievable by a typical dietary intake of isoflavones in adults, and glyceollins may be better absorbed in the gastrointestinal tract due to their relatively high hydrophobicity (70) . The present results indicate that glyceollins attenuate the growth of VASMC at 0·3 mg/ml (about 1 mM-glyceollin I) under the PDGF stimulation while glyceollins at 3 mg/ml (about 10 mMglyceollin I) completely abrogated the effect of PDGF.
Conclusion
The present results indicate that glyceollins inhibit PDGFinduced HASMC proliferation through G 0 /G 1 -S phase arrest by decreasing the expression of cyclin E and CDK2, and increasing the expression of p27 kip1 and p53. Inactivation of PDGFR-b, PLCg1, Akt, ERK, and reduction of ROS are presumed to be the possible mechanisms of the inhibitory effects of glyceollins. In addition to anti-proliferative effects, glyceollins have an anti-migrative effect on PDGF-stimulated HASMC. This property of glyceollins may play an important role for the beneficial effects on CVD and angioplasty.
